HSIC
51
6
PNR
59
2
UA
32
6
FOX
51
3
LUV
56
4
RL
70
-3
APA
46
-2
ZTS
19
3
DUK
49
2
LEN
17
-6
KR
59
2
NWSA
75
2
VTR
38
-3
LB
28
-7
LEG
43
3
TDC
49
-5
MHK
42
2
URI
56
4
KIM
51
-3
MMM
52
2
HSIC
51
6
PNR
59
2
UA
32
6
FOX
51
3
LUV
56
4
RL
70
-3
APA
46
-2
ZTS
19
3
DUK
49
2
LEN
17
-6
KR
59
2
NWSA
75
2
VTR
38
-3
LB
28
-7
LEG
43
3
TDC
49
-5
MHK
42
2
URI
56
4
KIM
51
-3
MMM
52
2
Financhill
Back

Apellis Pharmaceuticals Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.31
Seasonality Move:
-9.52%
Sell
37

REGN
Regeneron Pharmaceuticals

Last Price:
$509.35
Seasonality Move:
9.62%
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.69. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $509.72. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $509.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 42.98 Sell
Chaikin Money Flow: -561522 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.2 - 19.06) Sell
Bollinger Bands (100): (17.72 - 26.54) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -16.46 Sell
Relative Strength Index (14 RSI): 41.15 Sell
Chaikin Money Flow: -1248550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (496.22 - 589.92) Sell
Bollinger Bands (100): (546.65 - 682.05) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.56 Sell
20-day SMA: 18.3 Sell
50-day SMA: 18.27 Sell
200-day SMA: 26.83 Sell
8-day EMA: 18.25 Sell
20-day EMA: 18.36 Sell
50-day EMA: 19.23 Sell
200-day EMA: 26.97 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 518.51 Sell
20-day SMA: 529.08 Sell
50-day SMA: 558.53 Sell
200-day SMA: 749.9 Sell
8-day EMA: 515.45 Sell
20-day EMA: 528.44 Sell
50-day EMA: 561.38 Sell
200-day EMA: 706.03 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.42 per share, a decrease next quarter of $0.05 per share, a decrease this year of $9.47 per share, and an increase next year of $4.72 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):